Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:
View:
Post by C10H12N2 on Jan 07, 2022 4:53pm

HERE'S TO A SLEEPY & LAZY HOMEGROWN MESSAGE BOARD:

Comment by TheBearInTheWoods on Jan 08, 2022 9:15pm
Ouch, rough fact sheet! Thanks for posting so others understand why not to invest. Management takes a company from .58 down to .04 and then conduct a 100-1 consolidation.... Now they have 4 trials planned even though they couldn't execute the last two, can't imagine the dilution with a full warrant to come. Ouch again 
Comment by C10H12N2 on Jan 09, 2022 12:33pm
The fact is it's a great plan moving forward. So what, the stock split. There's been zero dilution since and if it remains ultra low i9t changes nothing in relation to someone's overall slice of the pie. It's just math. Also, it's the best strategy to go after the low hanging fruit first. The Stroke, Small Cell Lung Cancer, and Pancreatic Cancer can/will be looked at by Nasdaq ...more  
Comment by TheBearInTheWoods on Jan 09, 2022 3:12pm
Algernon is bragging that a company has a low float after a consolidation, That it has 4 trials for while it has no patents for and is not funded for. Management has a history of under market raises with a full Warrant, they need to pay those large wages. This guy who ever he is, is not looking out for shareholders and prob owns as little shares as management 
Comment by pigsandsheep on Jan 09, 2022 3:21pm
THEY HAVE 4 TRAILS...WOW WOW ...BUT WHAT HAPPENED WITH THE $12M THEY BLEW ON THEIR LAST "TRIALS" JUST MOVING TO NASDAQ WILL NOT GET A HUGE VALUATION...THEIR PAST RECORD ON "TRIALS" COMBINED WITH LACK OF ANY CREDIBLE SUCCESS BY MANAGEMENT IN THEIR CAREERS SPEAKS VOLUMES....JUST POINTING TO "4 TRIALS" AND "MOVING TO CASH RICH NASDAQ" IS JUST DREAMING MANY ...more  
Comment by TheBearInTheWoods on Jan 09, 2022 3:31pm
Very accurate post, South Korea trial - fail , Australian Trial - Fail , COVID trial Fail! Management Salary- Paid hey let's consolidate and do it again 
Comment by C10H12N2 on Jan 09, 2022 4:30pm
This post has been removed in accordance with Community Policy
Comment by TheBearInTheWoods on Jan 09, 2022 4:55pm
This post has been removed in accordance with Community Policy
Comment by C10H12N2 on Jan 09, 2022 5:08pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities